Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 4/20 | 0.34 |
| ▸ | TET3 | O43151 | 1/20 | 0.32 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.31 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5653894 | 0.87 | THRB (0.34) | TET2ALOX15HSD17B10 | |
| SCHEMBL5163345 | 0.85 | THRB (0.37) | ALOX15HSD17B10 | |
| SCHEMBL4919090 | 0.77 | TET2 (0.31) | TET2 | |
| SCHEMBL5711126 | 0.75 | FFAR3 (0.41) | ALOX15HSD17B10 | |
| SCHEMBL447743 | 0.70 | TET2 (0.39) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL28988584 | 0.70 | TET2 (0.32) | TET2TET3TET1 | |
| SCHEMBL17818 | 0.67 | — | — | |
| SCHEMBL4832840 | 0.67 | FFAR3 (0.32) | — | |
| SCHEMBL156659 | 0.66 | FFAR3 (0.47) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL17865 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040236130-A1 | Process for the preparation of trialkylsilated carboxylate monomers, the obatined trialkylsilated carboxylate monomers and their use in anti-fouling coatings | SIGMA COATINGS B.V. (NL) | 2004-11-25 | — | — | US | disclosed |
| EP-1389214-A1 | PROCESS FOR THE PREPARATION OF TRIALKYLSILYLATED CARBOXYLATE MONOMERS, THE OBTAINED TRIALKYLSILYLATED CARBOXYLATE MONOMERS AND THEIR USE IN ANTI-FOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2004-02-18 | — | — | EP | disclosed |
| WO-2002094838-A1 | PROCESS FOR THE PREPARATION OF TRIALKYLSILYLATED CARBOXYLATE MONOMERS, THE OBTAINED TRIALKYLSILYLATED CARBOXYLATE MONOMERS AND THEIR USE IN ANTI-FOULING COATINGS | SIGMA COATINGS B.V. (NL) | 2002-11-28 | — | — | WO | disclosed |
| EP-1260513-A1 | Process for the preparation of trialkylsilylated carboxylate monomers, the obtained trialkylsilylated carboxylate monomers and their use in antifouling coatings | SIGMA COATINGS B.V. (NL) | 2002-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236130-A1 | Process for the preparation of trialkylsilated carboxylate monomers, the obatined trialkylsilated carboxylate monomers and their use in anti-fouling coatings | ACMSD, OR10J3, CFD | TET2 1758/4885TET3 1141/4885TET1 1282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.